跳至主要内容
临床试验/ISRCTN45792044
ISRCTN45792044已完成不适用

Randomised trial of transcutaneous versus surgical aortic valve replacement

St George's Healthcare NHS Trust (UK)0 个研究点目标入组 657 人开始时间: 2009年5月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
657

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. After a multidisciplinary meeting, patients (both males ane females) with expected mortality >15% (Euroscore) and/or >10% (Society of Thoracic Surgeons Mortality Risk [STS] score)
  • 2. Severe aortic stenosis, confirmed by trans-thoracic echocardiography using a combination of measurements of valve area and flow dependent indices (mean gradient >50 mmHg). Low dose dobutamine echocardiography is useful to differentiate between severe and the rare 'pseudo-severe' aortic stenosis in patients with low left ventricular ejection fraction and low gradient.
  • 3. Severe aortic stenosis, +/- one vessel coronary artery disease amenable to percutaneous intervention
  • 4. Age >70 (if age <70, need to have other significant comorbidities)
  • 5. Symptomatic patients with New York Heart Association (NYHA) grade >II
  • 6. Patients who are able to give consent
  • 7. If it is thought that risks of mortality and morbidity with surgery outweigh the benefits, the patients will be randomised into cohort B

排除标准

  • 1. Aortic regurgitation
  • 2. Patient preference - TAVI is not recommended for patients who simply refuse surgery on the basis of personal preference
  • 3. Aortic annulus <18 or >25 mm for balloon expandable and <20 or >27 mm for self-expandable devices
  • 4. Bicuspid aortic valve
  • 5. Present of asymmetric heavy valvular calcification
  • 6. Aortic root dimensions >4.5 cms
  • 7. Presence of apical left ventricular thrombus
  • 8. Evidence of acute myocardial infarction <30 days
  • 9. Hypertrophic cardiomyopathy
  • 10. Life expectancy <1 year due to non-cardiac causes
  • Specific contraindications for transfemoral approach:
  • 1. Iliac arteries with severe calcification tortuousity and small diameter (6-9 mm), previous aorto-femoral bypass
  • 2. Severe angulation of aorta and atheroma of the outcome and coaptation, aneurysm of the abdominal aorta with mural thrombus
  • 3. Presence of bulky atherosclerosis of the ascending aorta and arch
  • Specific contraindications for the transapical approach:
  • 1. Previous surgery of the left ventricle using a patch such as the Dor procedure
  • 2. Calcified pericardium
  • 3. Severe respiratory insufficiency

研究者

发起方
St George's Healthcare NHS Trust (UK)

相似试验